HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 1119

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  

    Article Cited by others


Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence

Reid Savanna

Year : 2012| Volume: 37| Issue : 2 | Page no: 89-94

   This article has been cited by
1 Patient Safety, Clinical Microbiology, and Collaborative Healthcare
Tulsi Das Chugh, Ashish Kumar Duggal, Shalini Dewan Duggal
Annals of the National Academy of Medical Sciences (India). 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review
Anokhi Ali Khan, Mehr Munir, Fatima Miraj, Shayan Imran, Danya Arif Siddiqi, Arshad Altaf, Aamir Javed Khan, Subhash Chandir
Human Vaccines & Immunotherapeutics. 2021; 17(9): 3247
[Pubmed]  [Google Scholar] [DOI]
3 Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India
Pankaj Bahuguna,Shankar Prinja,Chandrakant Lahariya,Radha Krishan Dhiman,Madhumita Prem Kumar,Vineeta Sharma,Arun Kumar Aggarwal,Rajesh Bhaskar,Hilde De Graeve,Henk Bekedam
Applied Health Economics and Health Policy. 2020; 18(3): 393
[Pubmed]  [Google Scholar] [DOI]
4 Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C
Radha K. Dhiman,Gagandeep S. Grover,Madhumita Premkumar,Sunil Taneja,Ajay Duseja,Sahaj Rathi,Sandeep Satsangi
Journal of Pediatric Gastroenterology and Nutrition. 2019; 68(1): 74
[Pubmed]  [Google Scholar] [DOI]
5 Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
Antoine Chaillon,Sanjay R. Mehta,Martin Hoenigl,Sunil S. Solomon,Peter Vickerman,Matthew Hickman,Britt Skaathun,Natasha K. Martin,Yury E. Khudyakov
PLOS ONE. 2019; 14(6): e0217964
[Pubmed]  [Google Scholar] [DOI]
6 Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis
Hongyao Du,Pei Liu,Jinjin Zhu,Jiajia Lan,Yan Li,Lianbin Zhang,Jintao Zhu,Juan Tao
ACS Applied Materials & Interfaces. 2019; 11(46): 43588
[Pubmed]  [Google Scholar] [DOI]
7 Hepatitis C Virus (HCV) Prevalence and Risk of Unsafe Parenteral Practices in Derqui, Argentine
Jorge T Insua
Gastroenterology & Hepatology: Open Access. 2017; 6(1)
[Pubmed]  [Google Scholar] [DOI]
8 Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress
Naveed Zafar Janjua,Zahid Ahmad Butt,Bushra Mahmood,Arshad Altaf
World Journal of Gastroenterology. 2016; 22(25): 5837
[Pubmed]  [Google Scholar] [DOI]
9 Knowledge and Self-Reported Practice of Insulin Injection Device Disposal among Diabetes Patients in Gondar Town, Ethiopia: A Cross-Sectional Study
Abebe Basazn Mekuria,Begashaw Melaku Gebresillassie,Daniel Asfaw Erku,Kaleab Taye Haile,Eshetie Melese Birru
Journal of Diabetes Research. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]
10 Tackling the Hepatitis C Disease Burden in Punjab, India
Radha K. Dhiman,Sandeep Satsangi,Gagandeep S. Grover,Pankaj Puri
Journal of Clinical and Experimental Hepatology. 2016; 6(3): 224
[Pubmed]  [Google Scholar] [DOI]
11 A Systematic Review of the State of Economic Evaluation for Health Care in India
Shankar Prinja,Akashdeep Singh Chauhan,Blake Angell,Indrani Gupta,Stephen Jan
Applied Health Economics and Health Policy. 2015; 13(6): 595
[Pubmed]  [Google Scholar] [DOI]
12 A path to eradication of hepatitis C in low- and middle-income countries
Camilla S. Graham,Tracy Swan
Antiviral Research. 2015;
[Pubmed]  [Google Scholar] [DOI]
13 Treatment of chronic hepatitis C: What is new?
Anil C. Anand
Apollo Medicine. 2014;
[Pubmed]  [Google Scholar] [DOI]
14 Consensus Statement of HCV Task force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India
Pankaj Puri,Anil C. Anand,Vivek A. Saraswat,Subrat K. Acharya,Radha K. Dhiman,Rakesh Aggarwal,Shivram P. Singh,Deepak Amarapurkar,Anil Arora,Mohinish Chhabra,Kamal Chetri,Gourdas Choudhuri,Vinod K. Dixit,Ajay Duseja,A.K. Jain,Dharmesh Kapoorz,Premashis Kar,Abraham Koshy,Ashish Kumar,Kaushal Madan,Sri P. Misra,Mohan V.G. Prasad,Aabha Nagral,Amarendra S. Puri,R. Jeyamani,Sanjiv Saigal,Shiv K. Sarin,Samir Shah,P.K. Sharma,Ajit Sood,Sandeep Thareja,Manav Wadhawan
Journal of Clinical and Experimental Hepatology. 2014;
[Pubmed]  [Google Scholar] [DOI]
15 Tackling the Hepatitis B disease burden in India
Pankaj Puri
Journal of Clinical and Experimental Hepatology. 2014;
[Pubmed]  [Google Scholar] [DOI]
16 Spending of HIV resources in Asia and Eastern Europe: Systematic review reveals the need to shift funding allocations towards priority populations
Craig, A.P., Thein, H.-H., Zhang, L., (...), Gorgens, M., Wilson, D.P.
Source of the Document Journal of the International AIDS Society. 2014;
[Pubmed]  [Google Scholar]
17 Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations
Andrew P Craig,Hla-Hla Thein,Lei Zhang,Richard T Gray,Klara Henderson,David Wilson,Marelize Gorgens,David P Wilson
Journal of the International AIDS Society. 2014; 17(1): 18822
[Pubmed]  [Google Scholar] [DOI]
18 Is There a Need for Cluster Hepatitis B and C Epidemiological Studies in the Region?: Yes
Jorge T. Insua
Current Hepatitis Reports. 2013; 12(4): 288
[Pubmed]  [Google Scholar] [DOI]


Read this article
  Sitemap | What's New | Copyright and Disclaimer | Privacy Notice
  2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007